Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Amgen

11 clinical trials · 11 recruiting · INDUSTRY

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Amgen

RECRUITINGPhase 3NCT07037459

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent...

Sponsor: AmgenEnrolling: 505620 locations
Heart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection FractionObesity
RECRUITINGPhase 2NCT06570798

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

The main objective is to assess the safety and tolerability of inebilizumab in adult participants with active and refractory systemic lupus erythematosus (SLE) with nephritis...

Sponsor: AmgenEnrolling: 22020 locations
Systemic Lupus ErythematosusActive Refractory Rheumatoid Arthritis
RECRUITINGPhase 2NCT06987539

A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With...

The primary objectives of this study are to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of inebilizumab administered in pediatric participants with gMG, and...

Sponsor: AmgenEnrolling: 151 location
Generalized Myasthenia Gravis
RECRUITINGPhase 3NCT04528082

Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease

The aim of this study is to estimate the efficacy of apremilast compared to placebo in the treatment of oral ulcers in pediatric participants from 2 to \< 18 years of age with...

Sponsor: AmgenEnrolling: 6020 locations
Behçet Disease
RECRUITINGPhase 4NCT06072482

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

The primary objective of this study is to evaluate the long-term safety of avacopan in participants with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

Sponsor: AmgenEnrolling: 30020 locations
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
RECRUITINGPhase 3NCT05767047

A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis

The primary objective of this study is to evaluate the long-term safety of apremilast in subjects 2 years of age or older with oral ulcers associated with Behçets disease or 5...

Sponsor: AmgenEnrolling: 487 locations
Behçet's DiseaseJuvenile Psoriatic Arthritis
RECRUITINGPhase 3NCT07388498

A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase...

The primary objective of this trial is to evaluate the effect of pegloticase 18 mg subcutaneously (SC) every two weeks with methotrexate (MTX) versus pegloticase 8 mg...

Sponsor: AmgenEnrolling: 27020 locations
Uncontrolled Gout
RECRUITINGPhase 4NCT06588153

A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis...

The main objective of this study is to evaluate the efficacy of Prolia® in improving bone mass density (BMD) of lumbar spine at month 12.

Sponsor: AmgenEnrolling: 10016 locations
Glucocorticoid-induced Osteoporosis
RECRUITINGPhase 1 / Phase 2NCT06401044

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

The primary objective of Part A of this study is to investigate the safety and tolerability of AMG 732 after single subcutaneous (SC) doses. The primary objective of Part B of...

Sponsor: AmgenEnrolling: 8820 locations
Thyroid Eye Disease
RECRUITINGPhase 1NCT06637371

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and...

The main objective of this study is to assess the safety and tolerability of AMG 691 as single doses (healthy participants only) and multiple doses in healthy participants and...

Sponsor: AmgenEnrolling: 12419 locations
Asthma
RECRUITINGPhase 3NCT07226765

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway...

This Phase 3 clinical trial is designed to evaluate the efficacy and safety of maridebart cafraglutide compared to placebo over a 52-week period in adults with obstructive sleep...

Sponsor: AmgenEnrolling: 25020 locations
Obstructive Sleep Apnea